Streetbeat News

MHUA

Meihua International Medical Technologies Co., Ltd.

https://www.meihuamed.com

Industry

Medical - Instruments & Supplies

Meihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.

Open

0.61

Mkt cap

14M

Volume

1.5M

High

0.61

P/E Ratio

1.43

52-wk high

2.81

Low

0.52

Div yield

N/A

52-wk low

0.52

Meihua International Medical Technologies (NASDAQ: MHUA) has announced a share buyback program of up to $3 million. The company plans to cancel all repurchased shares.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:04 am

In Monday's pre-market session, health care stocks showed significant movement. Deciphera Pharmaceuticals led the gainers with a 71.0% increase, while Addex Therapeutics experienced the largest drop, declining by 53.9%. Other notable movers include Koninklijke Philips with a 40.91% increase following their Q1 earnings release, and Cyclacel Pharmaceuticals dropping by 20.53%.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 12:07 pm

In Thursday's after-market session, several healthcare stocks showed significant movement. Biolase, Terns Pharma, Aptevo Therapeutics, Nexalin Technology, Evolus, and Phio Pharma were among the gainers, with Biolase leading by a 20% increase following their Q4 earnings release. On the downside, Cutera, Hyperfine, China SXT Pharmaceuticals, Vicarious Surgical, Meihua Intl Medical Techs, and Assure Holdings experienced declines, with Cutera dropping 11.7% after their Q4 earnings announcement.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 9:33 pm

In Thursday's pre-market session, several healthcare stocks showed significant movement. Notably, Applied Therapeutics, Meihua Intl Medical Techs, and KalVista Pharma were among the top gainers, with increases of 24.6%, 24.32%, and 15.83% respectively. On the losing end, Vivos Therapeutics saw a dramatic drop of 54.7%, followed by Renalytix and FibroBiologics with declines of 27.26% and 20.01% respectively. American Well, Renalytix, and Adaptive Biotechnologies released their Q4 earnings, influencing their stock movements.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 1:05 pm

AppLovin Corporation's shares surged by approximately 22% in pre-market trading after reporting Q4 earnings and sales that exceeded analyst expectations. Other stocks also showed significant movement in pre-market trading, with notable gainers including China Natural Resources, Inc., and JFrog Ltd., and losers like Treasure Global Inc., and Cineverse Corp.

Portfolio Pulse from Avi Kapoor

February 15, 2024 | 12:57 pm

During Friday's intraday session, several healthcare stocks experienced significant movements. China SXT Pharmaceuticals (SXTC) saw a 108.8% increase, while cbdMD (YCBD) rose by 73.85%. Other gainers included Qilian Intl Hldg Gr (QLI), Aditxt (ADTX), RenovoRx (RNXT), and Jin Medical International (ZJYL). Conversely, Processa Pharma (PCSA), Bone Biologics (BBLG), Fortress Biotech (FBIO), Meihua Intl Medical Techs (MHUA), SenesTech (SNES), and Microbot Medical (MBOT) faced declines.

Portfolio Pulse from Benzinga Insights

December 29, 2023 | 5:31 pm

DouYu International Holdings Limited (NASDAQ:DOYU) announced a share repurchase program of up to $20 million of ordinary shares in the form of ADSS, causing its shares to rise by 14.2% to $0.8320. Other stocks experienced significant movements in Thursday's mid-day session, with various companies seeing substantial gains and losses for diverse reasons, including FDA guidance, analyst ratings, public offerings, and patent lawsuit outcomes.

Portfolio Pulse from Avi Kapoor

December 28, 2023 | 6:07 pm

Health care stocks experienced significant movement in Thursday's intraday session. Cingulate, SenesTech, Jin Medical International, Microbot Medical, Ocean Biomedical, and Bone Biologics saw their shares rise by 125.8%, 107.53%, 58.53%, 36.71%, 30.51%, and 27.53% respectively. Conversely, CytoSorbents, Bluejay Diagnostics, Meihua Intl Medical Techs, IMAC Hldgs, P3 Health Partners, and NeoGenomics witnessed declines in their share prices by 38.7%, 29.18%, 29.16%, 23.71%, 19.55%, and 18.49% respectively.

Portfolio Pulse from Benzinga Insights

December 28, 2023 | 5:31 pm

MHUA shares dropped following the announcement of a securities purchase agreement to issue and sell an initial $6 million tranche as part of a larger $50.5 million securities offering.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 3:51 pm

Meihua International Medical Technologies Co. has entered into a securities purchase agreement with investors to issue and sell an initial tranche of $6 million as part of a larger offering totaling $50.5 million of its securities.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 2:01 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.